Immunogenicity of variable regions of the surface envelope glycoprotein of HTLV type I and identification of new major epitopes in the 239-261 region

• Published in: AIDS research and human retroviruses Vol. 12; no. 10; p. 941
• Main Authors: Londos-Gagliardi, D, Dalibart, R, Geoffre, S, Dalbon, P, Pouliquen, J F, Georges-Courbot, M C, Sainte-Foie, S, Hajjar, C, Georges, A J, Moreau, J P, Guillemain, B
• Format: Journal Article
• Language: English
• Published: United States 01.07.1996
• Subjects: Amino Acid Sequence; Epitope Mapping; Gene Products, env - immunology; HTLV-I Antibodies - blood; HTLV-I Infections - blood; HTLV-I Infections - immunology; Human T-lymphotropic virus 1 - immunology; Humans; Immunodominant Epitopes - immunology; Molecular Sequence Data; Retroviridae Proteins, Oncogenic - immunology
• ISSN: 0889-2229
• DOI: 10.1089/aid.1996.12.941

The reactivity of sera of 96 individuals infected with human T-cell leukemia virus type I (HTLV-I) was tested against various synthetic peptides corresponding to the gp46 immunodominant antigenic domains: residues 86-107, 175-199, and 239-261. The frequency of reactive sera was higher for 175-199 (93%) than for 239-261 (78%) or 86-107 (24%) with some variations in geographical regions and in diseases. The region 239-261 was extensively analyzed and five (linear or conformational) epitopes were found. The reactivity of sera toward functional or immunodominant domains may depend on the sequence of the infecting virus, and the role of three frequent substitutions (asparagine by tyrosine, proline by serine, and serine by proline or leucine at positions 93, 192, and 250 respectively) was established. Finally, the role of the genetic background of the host may condition the humoral immune response as individuals infected by HTLV-Is harboring the same predicted gp46 peptide sequence may recognize one, several, or all regions examined.